CAM
ANIP icon

Cortina Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History

Cortina Asset Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-73,218
Closed -$4.14M – 220
2018
Q3 		$4.14M Sell
73,218
-8,450
-10% -$517K 0.19% 189
2018
Q2 		$5.46M Sell
81,668
-1,450
-2% -$90.5K 0.26% 153
2018
Q1 		$4.84M Sell
83,118
-11,390
-12% -$723K 0.24% 168
2017
Q4 		$6.09M Buy
+94,508
New +$5.88M 0.27% 144

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Cortina Asset Management's ANIP Position: Q4 2018 in Review

Cortina Asset Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2018, closing a stake of 73,218 shares — an estimated $4.14M sold.

Cortina Asset Management first reported a position in ANIP in Q4 2017 and held it in 4 quarters. The position peaked at $6.09M in Q4 2017. 170 funds tracked by Wall St. Rank hold ANIP as of Q4 2018.

  • Cortina Asset Management reported no remaining ANI Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Cortina Asset Management sold 73,218 ANI Pharmaceuticals shares in Q4 2018, an estimated $4.14M.
  • Cortina Asset Management first reported a position in ANI Pharmaceuticals in Q4 2017 and held it in 4 quarters.
  • Cortina Asset Management's ANI Pharmaceuticals position peaked at $6.09M in Q4 2017.
  • 170 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2018.

Based on Cortina Asset Management's 13F filing for Q4 2018, filed 12 Feb 2019.